Off-Label Use of Medical Devices in Children

,

    Pediatrics
    |December 28, 2016
    PubMed

    Insights

    Most medical devices for children lack Food and Drug Administration (FDA) approval. Off-label use of these devices is often necessary and appropriate for pediatric care, despite regulatory complexities.

    Area of Science:

    • Pediatric Medical Devices
    • Regulatory Science
    • Clinical Practice

    Background:

    • Most medical and surgical devices used in children lack specific Food and Drug Administration (FDA) approval for pediatric use.
    • Off-label or physician-directed use of FDA-approved devices is a common and often necessary practice in pediatric medicine and surgery.

    Purpose of the Study:

    • To describe the appropriateness of off-label device use in children.
    • To discuss FDA regulatory pathways for pediatric devices, including the Humanitarian Device Exemption.
    • To highlight the need for increased pediatric device labeling.

    Main Methods:

    • Policy statement analysis.
    • Review of FDA regulatory frameworks for medical devices.
    • Examination of challenges in pediatric device development.

    Main Results:

    • Off-label use of medical devices, even high-risk ones, is a necessary component of pediatric care due to unmet needs and development challenges.
    • Regulatory pathways like the Humanitarian Device Exemption can cause confusion regarding device experimental status.
    • Significant economic and market barriers hinder the development of new pediatric devices.

    Conclusions:

    • Off-label device use in children is appropriate and essential.
    • Enhanced pediatric device labeling is crucial for safe and effective care.
    • Addressing regulatory and economic barriers is vital to improve pediatric device availability.

    Related Concept Videos

    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    637
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    343
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    407
    Prescription, Nonprescription and Orphan Drugs01:02

    Prescription, Nonprescription and Orphan Drugs

    Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
    The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
    1.3K
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    306
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    595